Unblocking the barriers of access to direct-acting antiviral-based hepatitis C treatment in China: lessons learnt from Tianjin city
Peiwen Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jing Sun(Dana-Farber Cancer Institute), Polin Chan(Western University), Zhongdan Chen(World Health Organization - Pakistan), Lihong Wang(Nanjing University of Chinese Medicine), Chengzhen Lu(Tianjin People's Hospital), Ran Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), WU Wei-shen(Tianjin Centers for Disease Control and Prevention), Mengjia Zhi(Chinese Academy of Medical Sciences & Peking Union Medical College), Jun Lian(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 0
Related Papers
Global reporting of progress towards elimination of hepatitis B and hepatitis C
|The Lancet. Gastroenterology & hepatology|2023|323
Hepatitis B virus infection in children and adolescents
|The Lancet. Gastroenterology & hepatology|2019|258
Drying kinetics and quality of Monukka seedless grapes dried in an air-impingement jet dryer
|Biosystems Engineering|2009|235
Gestational diabetes mellitus in the last trimester – a feature of maternal iron excess?
|Diabetic Medicine|2001|139
HIV epidemiology and responses among men who have sex with men and transgender individuals in China: a scoping review
|BMC Infectious Diseases|2016|122